China Oral Polio Vaccines (OPV) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Oral Polio Vaccines (OPV) market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Oral Polio Vaccines (OPV) market. Detailed analysis of key players, along with key growth strategies adopted by Oral Polio Vaccines (OPV) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Halfkin Bio-Pharmaceuticals

    • Serum Institute

    • Sanofi

    • Bibcol

    • Tiantan Biological

    • Bio-Med

    • Panacea Biotec Ltd

    • GSK

    By Type:

    • Trivalent OPV

    • Bivalent OPV

    By End-User:

    • Public

    • Private

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Polio Vaccines (OPV) Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Trivalent OPV from 2016 to 2027

    • 1.3.2 China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Bivalent OPV from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Public from 2016 to 2027

    • 1.4.2 China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Private from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Oral Polio Vaccines (OPV) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oral Polio Vaccines (OPV) by Major Types

    • 3.4.1 Market Size and Growth Rate of Trivalent OPV

    • 3.4.2 Market Size and Growth Rate of Bivalent OPV

    4 Segmentation of Oral Polio Vaccines (OPV) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oral Polio Vaccines (OPV) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Oral Polio Vaccines (OPV) in Public

    • 4.4.2 Market Size and Growth Rate of Oral Polio Vaccines (OPV) in Private

    5 Market Analysis by Regions

    • 5.1 China Oral Polio Vaccines (OPV) Production Analysis by Regions

    • 5.2 China Oral Polio Vaccines (OPV) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Oral Polio Vaccines (OPV) Landscape Analysis

    • 6.1 North China Oral Polio Vaccines (OPV) Landscape Analysis by Major Types

    • 6.2 North China Oral Polio Vaccines (OPV) Landscape Analysis by Major End-Users

    7 Central China Oral Polio Vaccines (OPV) Landscape Analysis

    • 7.1 Central China Oral Polio Vaccines (OPV) Landscape Analysis by Major Types

    • 7.2 Central China Oral Polio Vaccines (OPV) Landscape Analysis by Major End-Users

    8 South China Oral Polio Vaccines (OPV) Landscape Analysis

    • 8.1 South China Oral Polio Vaccines (OPV) Landscape Analysis by Major Types

    • 8.2 South China Oral Polio Vaccines (OPV) Landscape Analysis by Major End-Users

    9 East China Oral Polio Vaccines (OPV) Landscape Analysis

    • 9.1 East China Oral Polio Vaccines (OPV) Landscape Analysis by Major Types

    • 9.2 East China Oral Polio Vaccines (OPV) Landscape Analysis by Major End-Users

    10 Northeast China Oral Polio Vaccines (OPV) Landscape Analysis

    • 10.1 Northeast China Oral Polio Vaccines (OPV) Landscape Analysis by Major Types

    • 10.2 Northeast China Oral Polio Vaccines (OPV) Landscape Analysis by Major End-Users

    11 Southwest China Oral Polio Vaccines (OPV) Landscape Analysis

    • 11.1 Southwest China Oral Polio Vaccines (OPV) Landscape Analysis by Major Types

    • 11.2 Southwest China Oral Polio Vaccines (OPV) Landscape Analysis by Major End-Users

    12 Northwest China Oral Polio Vaccines (OPV) Landscape Analysis

    • 12.1 Northwest China Oral Polio Vaccines (OPV) Landscape Analysis by Major Types

    • 12.2 Northwest China Oral Polio Vaccines (OPV) Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Halfkin Bio-Pharmaceuticals

      • 13.1.1 Halfkin Bio-Pharmaceuticals Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Serum Institute

      • 13.2.1 Serum Institute Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Sanofi

      • 13.3.1 Sanofi Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Bibcol

      • 13.4.1 Bibcol Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Tiantan Biological

      • 13.5.1 Tiantan Biological Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Bio-Med

      • 13.6.1 Bio-Med Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Panacea Biotec Ltd

      • 13.7.1 Panacea Biotec Ltd Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 GSK

      • 13.8.1 GSK Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Trivalent OPV from 2016 to 2027

    • Figure China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Bivalent OPV from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Public from 2016 to 2027

    • Figure China Oral Polio Vaccines (OPV) Market Size and Growth Rate of Private from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Oral Polio Vaccines (OPV) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Oral Polio Vaccines (OPV) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Oral Polio Vaccines (OPV)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oral Polio Vaccines (OPV) by Different Types from 2016 to 2027

    • Table Consumption Share of Oral Polio Vaccines (OPV) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Trivalent OPV

    • Figure Market Size and Growth Rate of Bivalent OPV

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Oral Polio Vaccines (OPV) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Oral Polio Vaccines (OPV) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Public

    • Figure Market Size and Growth Rate of Private

    • Table China Oral Polio Vaccines (OPV) Production by Regions

    • Table China Oral Polio Vaccines (OPV) Production Share by Regions

    • Figure China Oral Polio Vaccines (OPV) Production Share by Regions in 2016

    • Figure China Oral Polio Vaccines (OPV) Production Share by Regions in 2021

    • Figure China Oral Polio Vaccines (OPV) Production Share by Regions in 2027

    • Table China Oral Polio Vaccines (OPV) Consumption by Regions

    • Table China Oral Polio Vaccines (OPV) Consumption Share by Regions

    • Figure China Oral Polio Vaccines (OPV) Consumption Share by Regions in 2016

    • Figure China Oral Polio Vaccines (OPV) Consumption Share by Regions in 2021

    • Figure China Oral Polio Vaccines (OPV) Consumption Share by Regions in 2027

    • Table North China Oral Polio Vaccines (OPV) Consumption by Types from 2016 to 2027

    • Table North China Oral Polio Vaccines (OPV) Consumption Share by Types from 2016 to 2027

    • Figure North China Oral Polio Vaccines (OPV) Consumption Share by Types in 2016

    • Figure North China Oral Polio Vaccines (OPV) Consumption Share by Types in 2021

    • Figure North China Oral Polio Vaccines (OPV) Consumption Share by Types in 2027

    • Table North China Oral Polio Vaccines (OPV) Consumption by End-Users from 2016 to 2027

    • Table North China Oral Polio Vaccines (OPV) Consumption Share by End-Users from 2016 to 2027

    • Figure North China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2016

    • Figure North China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2021

    • Figure North China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2027

    • Table Central China Oral Polio Vaccines (OPV) Consumption by Types from 2016 to 2027

    • Table Central China Oral Polio Vaccines (OPV) Consumption Share by Types from 2016 to 2027

    • Figure Central China Oral Polio Vaccines (OPV) Consumption Share by Types in 2016

    • Figure Central China Oral Polio Vaccines (OPV) Consumption Share by Types in 2021

    • Figure Central China Oral Polio Vaccines (OPV) Consumption Share by Types in 2027

    • Table Central China Oral Polio Vaccines (OPV) Consumption by End-Users from 2016 to 2027

    • Table Central China Oral Polio Vaccines (OPV) Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2016

    • Figure Central China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2021

    • Figure Central China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2027

    • Table South China Oral Polio Vaccines (OPV) Consumption by Types from 2016 to 2027

    • Table South China Oral Polio Vaccines (OPV) Consumption Share by Types from 2016 to 2027

    • Figure South China Oral Polio Vaccines (OPV) Consumption Share by Types in 2016

    • Figure South China Oral Polio Vaccines (OPV) Consumption Share by Types in 2021

    • Figure South China Oral Polio Vaccines (OPV) Consumption Share by Types in 2027

    • Table South China Oral Polio Vaccines (OPV) Consumption by End-Users from 2016 to 2027

    • Table South China Oral Polio Vaccines (OPV) Consumption Share by End-Users from 2016 to 2027

    • Figure South China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2016

    • Figure South China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2021

    • Figure South China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2027

    • Table East China Oral Polio Vaccines (OPV) Consumption by Types from 2016 to 2027

    • Table East China Oral Polio Vaccines (OPV) Consumption Share by Types from 2016 to 2027

    • Figure East China Oral Polio Vaccines (OPV) Consumption Share by Types in 2016

    • Figure East China Oral Polio Vaccines (OPV) Consumption Share by Types in 2021

    • Figure East China Oral Polio Vaccines (OPV) Consumption Share by Types in 2027

    • Table East China Oral Polio Vaccines (OPV) Consumption by End-Users from 2016 to 2027

    • Table East China Oral Polio Vaccines (OPV) Consumption Share by End-Users from 2016 to 2027

    • Figure East China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2016

    • Figure East China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2021

    • Figure East China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2027

    • Table Northeast China Oral Polio Vaccines (OPV) Consumption by Types from 2016 to 2027

    • Table Northeast China Oral Polio Vaccines (OPV) Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Oral Polio Vaccines (OPV) Consumption Share by Types in 2016

    • Figure Northeast China Oral Polio Vaccines (OPV) Consumption Share by Types in 2021

    • Figure Northeast China Oral Polio Vaccines (OPV) Consumption Share by Types in 2027

    • Table Northeast China Oral Polio Vaccines (OPV) Consumption by End-Users from 2016 to 2027

    • Table Northeast China Oral Polio Vaccines (OPV) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2016

    • Figure Northeast China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2021

    • Figure Northeast China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2027

    • Table Southwest China Oral Polio Vaccines (OPV) Consumption by Types from 2016 to 2027

    • Table Southwest China Oral Polio Vaccines (OPV) Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Oral Polio Vaccines (OPV) Consumption Share by Types in 2016

    • Figure Southwest China Oral Polio Vaccines (OPV) Consumption Share by Types in 2021

    • Figure Southwest China Oral Polio Vaccines (OPV) Consumption Share by Types in 2027

    • Table Southwest China Oral Polio Vaccines (OPV) Consumption by End-Users from 2016 to 2027

    • Table Southwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2016

    • Figure Southwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2021

    • Figure Southwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2027

    • Table Northwest China Oral Polio Vaccines (OPV) Consumption by Types from 2016 to 2027

    • Table Northwest China Oral Polio Vaccines (OPV) Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Oral Polio Vaccines (OPV) Consumption Share by Types in 2016

    • Figure Northwest China Oral Polio Vaccines (OPV) Consumption Share by Types in 2021

    • Figure Northwest China Oral Polio Vaccines (OPV) Consumption Share by Types in 2027

    • Table Northwest China Oral Polio Vaccines (OPV) Consumption by End-Users from 2016 to 2027

    • Table Northwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2016

    • Figure Northwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2021

    • Figure Northwest China Oral Polio Vaccines (OPV) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Halfkin Bio-Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Halfkin Bio-Pharmaceuticals

    • Table Product and Service Introduction of Halfkin Bio-Pharmaceuticals

    • Table Company Profile and Development Status of Serum Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute

    • Figure Sales and Growth Rate Analysis of Serum Institute

    • Figure Revenue and Market Share Analysis of Serum Institute

    • Table Product and Service Introduction of Serum Institute

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Bibcol

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bibcol

    • Figure Sales and Growth Rate Analysis of Bibcol

    • Figure Revenue and Market Share Analysis of Bibcol

    • Table Product and Service Introduction of Bibcol

    • Table Company Profile and Development Status of Tiantan Biological

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiantan Biological

    • Figure Sales and Growth Rate Analysis of Tiantan Biological

    • Figure Revenue and Market Share Analysis of Tiantan Biological

    • Table Product and Service Introduction of Tiantan Biological

    • Table Company Profile and Development Status of Bio-Med

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Med

    • Figure Sales and Growth Rate Analysis of Bio-Med

    • Figure Revenue and Market Share Analysis of Bio-Med

    • Table Product and Service Introduction of Bio-Med

    • Table Company Profile and Development Status of Panacea Biotec Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec Ltd

    • Figure Sales and Growth Rate Analysis of Panacea Biotec Ltd

    • Figure Revenue and Market Share Analysis of Panacea Biotec Ltd

    • Table Product and Service Introduction of Panacea Biotec Ltd

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.